Hepatitis B: a new weapon against an old enemy - Nature Medicine

日本 ニュース ニュース

Hepatitis B: a new weapon against an old enemy - Nature Medicine
日本 最新ニュース,日本 見出し
  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 53%

In our recent News and Views, T. Jake Liang from NIDDKgov discusses new strategies based on nucleic acid technologies to treat chronic hepatitis B WorldHepatitisDay

Chronic infection with hepatitis B virus afflicts more than 250 million people worldwide.

Effective vaccines and treatments that potently suppress viral levels and reduce liver inflammation have been available for over 20 years, but infection with HBV continues to exact a heavy public-health toll. The goal of a ‘cure’ for chronic infection with HBV remains elusive. At present, nucleoside analogs and interferon-α are the only approved therapies, and they rarely cure the infection

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

NatureMedicine /  🏆 451. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

A blueprint for eliminating cholera by 2030 - Nature MedicineA blueprint for eliminating cholera by 2030 - Nature MedicineCholera is endemic in 47 countries, but deaths from this disease can be eliminated with a package of low-cost measures implemented by community healthcare workers.
続きを読む »

Financing the health needs of Ukrainian refugees - Nature MedicineFinancing the health needs of Ukrainian refugees - Nature MedicineFinancing the health needs of Ukrainian refugees. Correspondence from Wu Zeng Georgetown.
続きを読む »

Symptoms and risk factors for long COVID in non-hospitalized adults - Nature MedicineSymptoms and risk factors for long COVID in non-hospitalized adults - Nature MedicineA retrospective analysis of primary care records in the UK reveals individual symptoms associated with SARS-CoV-2 infections that persisted for 12 weeks or more post-infection, as well as risk factors associated with developing LongCOVID unibirmingham
続きを読む »

Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial - Nature MedicineSafety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial - Nature MedicineA first-in-human study of an antisense oligonucleotide targeting hepatitis B virus RNA provides initial insights into this potential new therapeutic modality for individuals with chronic HBV infection ASO HKUniversity NMEDClinical WorldHepatitisDay
続きを読む »

Global elimination of hepatitis C virus by 2030: why not? - Nature MedicineGlobal elimination of hepatitis C virus by 2030: why not? - Nature MedicineThe World Health Organization’s targets for eliminating hepatitis C virus by 2030 have been deemed ambitious by many. However, we believe they are achievable, provided they are supported by global commitment.
続きを読む »

Genetic risk score enhances the risk prediction of severe obesity in adult survivors of childhood cancer - Nature MedicineGenetic risk score enhances the risk prediction of severe obesity in adult survivors of childhood cancer - Nature MedicineA report from large cohorts of adult survivors of childhood cancer demonstrates that polygenic scores improve the risk prediction of developing severe obesity, providing opportunities for surveillance and mitigation interventions YadavSapkota8 StJude
続きを読む »



Render Time: 2025-03-10 04:24:08